Pherin Pharmaceuticals is a privately held clinical stage drug development company headquartered in Mountain View, California. We focus on the development of proprietary compounds called pherines, for the acute treatment of neuropsychiatric and neuroendocrine conditions.
Pherin Pharmaceuticals is led by a highly experienced senior management team. We have assembled a network of external experts to bring our products through all aspects of development successfully. Pherin product candidates currently include:
- PH94B for Treatment of Social Anxiety Disorder (licensed to VistaGen Therapeutics)
- PH10 for Treatment of Depression (licensed to VistaGen Therapeutics)
- PH80-HF for Treatment of Menopausal Hot Flashes
- PH15 for Cognitive Improvement
- PH284 for increasing appetite in anorexic patients